108 related articles for article (PubMed ID: 698929)
1. Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate.
Ablin RJ; Bhatti RA; Guinan PD
Cancer Res; 1978 Nov; 38(11 Pt 1):3702-6. PubMed ID: 698929
[TBL] [Abstract][Full Text] [Related]
2. Further evaluation of the effect of estrogen on tumor-associated immunity in prostatic cancer.
Ablin RJ; Bhatti RA; Guinan PD
Isr J Med Sci; 1979 Jan; 15(1):9-11. PubMed ID: 422345
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancer.
Ablin RJ; Bhatti RA; Guinan PD; Khin W
Clin Exp Immunol; 1979 Oct; 38(1):83-91. PubMed ID: 93529
[TBL] [Abstract][Full Text] [Related]
4. Arming of normal leukocytes with sera from patients with adenocarcinoma of the prostate.
Bhatti RA; Ablin RJ; Condoulis W; Guinan PD
Cancer Res; 1979 Sep; 39(9):3328-31. PubMed ID: 476662
[TBL] [Abstract][Full Text] [Related]
5. Possible suppression of host resistance by estrogen therapy for prostatic cancer.
Ablin RJ
Can Med Assoc J; 1976 Dec; 115(11):1082-4. PubMed ID: 1000436
[TBL] [Abstract][Full Text] [Related]
6. Hormonal therapy and alterations of immunity in prostatic cancer.
Ablin RJ
Neoplasma; 1981; 28(3):345-50. PubMed ID: 7290262
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated immunity in prostatic cancer as evaluated by tube antigen-induced leukocyte adherence inhibition: reactivity and specificity of responsiveness, and relationship to stage, grade and therapy.
Bhatti RA; Ablin RJ; Guinan PD
J Reticuloendothel Soc; 1979 Apr; 25(4):389-95. PubMed ID: 458777
[No Abstract] [Full Text] [Related]
8. Modulatory effects of estrogen on immunologic responsiveness. III. Effect of hormonal versus nonhormonal therapy on tumor-associated immunity in prostatic cancer.
Ablin RJ
Am J Reprod Immunol (1980); 1981 Aug; 1(4):206-9. PubMed ID: 7337156
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory effects of oestrogen in prostatic cancer: update and further consideration.
Ablin RJ
Allergol Immunopathol (Madr); 1981; 9(1):63-70. PubMed ID: 7258047
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
Grosser N; Thomson DM
Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
[TBL] [Abstract][Full Text] [Related]
11. Effect of human seminal plasma on tumour-associated immunity in patients with adenocarcinoma of the prostate.
Ablin RJ; Bhatti RA; Bush IM; Guinan PD
J Reprod Immunol; 1980 Feb; 1(5-6):337-45. PubMed ID: 7411523
[TBL] [Abstract][Full Text] [Related]
12. In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy.
Urist MM; Boddie AW; Townsend CM; Holmes EC
J Thorac Cardiovasc Surg; 1977 Feb; 73(2):189-94. PubMed ID: 834057
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immunity in prostatic cancer.
Ablin RJ; Bhatti RA; Nagubadi S; Zamora S; Guinan PD
Clin Oncol; 1980 Sep; 6(3):253-64. PubMed ID: 7428203
[No Abstract] [Full Text] [Related]
15. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration.
Ablin RJ; Marrow C; Guinan PD; Bruns GR; Sadoughi N; John T; Bush IM
Urol Int; 1976; 31(6):444-58. PubMed ID: 1006873
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancer.
Ablin RJ; Bhatti RA; Bush IM; Guinan PD
Eur Urol; 1980; 6(4):225-8. PubMed ID: 7389776
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma R-3327 of the Copenhagen rat as a suitable model for immunological studies of prostate cancer.
Lopez DM; Voigt W
Cancer Res; 1977 Jul; 37(7 Pt 1):2057-61. PubMed ID: 301055
[TBL] [Abstract][Full Text] [Related]
18. [Cellular immunity in prostatic cancer modified by Cytonal, Estrazyt and Turisteron].
Klebingat KJ; Panzig E; Lorenz G; Steinhauser I; Fiedler R
Z Urol Nephrol; 1987 Mar; 80(3):139-47. PubMed ID: 3300097
[TBL] [Abstract][Full Text] [Related]
19. Effect of diethylstilboesterol diphosphate on tumour-assoiciated immunity in prostatic cancer. A preliminary report.
Bhatti RA; Ablin RJ; Guinan PD; Totonchi E; Zamora S
Experientia; 1978 Oct; 34(10):1364-5. PubMed ID: 738427
[No Abstract] [Full Text] [Related]
20. Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy.
Noonan FP; Halliday WJ; Wall DR; Clunie GJ
Cancer Res; 1977 Aug; 37(8 Pt 1):2473-80. PubMed ID: 872076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
